The discovery of Huntington disease genetics: A paradigm for trinucleotide repeat disorders

Notice: Blog posts are not subject to review by MedLink Neurology’s Editorial Board. MedLink acknowledges using artificial intelligence to assist in the creation of blog posts.

Huntington disease is a devastating neurodegenerative disorder characterized by progressive motor dysfunction, psychiatric symptoms, and cognitive decline. For much of the 20th century, the heritability of Huntington disease was recognized, but the precise genetic basis remained elusive. The breakthrough came in the early 1990s, fueled by a unique opportunity to study a large extended family in Venezuela. This investigation not only identified the genetic mutation responsible for Huntington disease but also set the stage for understanding a broader category of genetic disorders involving trinucleotide repeat expansions.

The Venezuelan connection

Key to unraveling the genetics of Huntington disease was a remarkable family in Venezuela, the largest documented cluster of Huntington disease patients in the world. The family resided in the Lake Maracaibo region, where Huntington disease had been prevalent for generations. This cluster was traced back to a common ancestor, a woman who lived in the 19th century and whose descendants included thousands of individuals at risk for Huntington disease.

In the 1970s and 1980s, American physician Dr. Nancy Wexler spearheaded a large-scale study involving this family. Wexler’s work, supported by the Hereditary Disease Foundation and extensive collaboration with local Venezuelan scientists, was instrumental in mapping the Huntington disease gene. Field researchers collected detailed family histories, performed clinical evaluations, and gathered blood samples from over 18,000 individuals—an extraordinary dataset that would prove pivotal in the hunt for the Huntington disease gene.

The discovery of the Huntington disease gene

The Venezuelan study laid the groundwork for genetic linkage analysis, enabling researchers to localize the Huntington disease gene to the short arm of chromosome 4 in 1983. This achievement was among the first successes of positional cloning, a revolutionary method at the time. After a decade of meticulous work, the specific mutation causing Huntington disease was identified in 1993: an expanded CAG trinucleotide repeat in the HTT (huntingtin) gene.

Normal individuals have fewer than 35 CAG repeats, whereas patients with Huntington disease typically have more than 40. This expansion leads to the production of an abnormally long polyglutamine chain in the huntingtin protein, causing it to misfold and aggregate—a hallmark of Huntington disease pathology. Importantly, the number of repeats correlates with disease onset and severity, providing a molecular explanation for the variability in Huntington disease symptoms.

A new paradigm: trinucleotide repeat disorders

The discovery of the Huntington disease mutation had far-reaching implications because it marked the first genetic disease linked to trinucleotide repeat expansions. This breakthrough established a framework for studying other neurodegenerative and developmental disorders characterized by similar mutations, including:

• Fragile X syndrome: Caused by CGG repeats in the FMR1 gene.
• Myotonic dystrophy: Linked to CTG repeats in the DMPK gene.
• Spinocerebellar ataxias: Many of which are caused by CAG repeats in different genes.

Huntington disease became the archetype for understanding these conditions, demonstrating how unstable repeat expansions could drive pathogenesis, often with intergenerational instability that leads to earlier onset in successive generations (anticipation).

Impacts beyond Huntington disease

The insights gained from the Venezuelan Huntington disease family and the subsequent discovery of the HTT mutation revolutionized genetics and neuroscience. Huntington disease research continues to inspire therapeutic approaches, including gene-silencing technologies and precision medicine. Moreover, the study underscored the importance of collaboration and engagement with local communities in advancing global health research.

The legacy of this discovery extends beyond Huntington disease, offering a blueprint for understanding and treating other genetic diseases. It is a testament to how a single breakthrough can reshape an entire field of medicine.

Related MedLink Neurology News & More content:

• George Huntington: The physician who pioneered the understanding of Huntington disease
• Ethical dimensions of Huntington disease and genetic testing
• BrainWaves #126 HD part 1: Differential diagnosis and clinical features
• BrainWaves #127 HD part 2: Current and emerging therapeutics
  

Are you interested in contributing a post or becoming a guest blogger for MedLink? Contact us at editorial@medlink.com.